Codexis Is Chasing a Blockbuster Opportunity. Can It Compete With Gene Therapies? [The Motley Fool]
Codexis, Inc. (CDXS)
Last codexis, inc. earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.codexis.com/investors
Company Research
Source: The Motley Fool
Codexis Is Chasing a Blockbuster Opportunity. Can It Compete With Gene Therapies? The company is developing a novel enzyme-based treatment for phenylketonuria (PKU), but it faces growing competition from potentially curative gene therapies. Maxx Chatsko (TMFBlackn) Author Bio Maxx has been a contributor to Fool.com since 0. He graduated from the State University of New York College of Environmental Science and Forestry (0) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (0) with a Master of Science in Materials Science & Engineering. Genetic medicines and cellular therapies have an enormous potential to treat, and possibly cure, currently untreatable diseases. Nonetheless, it's important for investors to remember that "simpler" treatment options won't become obsolete just because gene therapy, gene editing, and immunotherapy approaches are becoming feasible. Investors are hoping that the 'simple is better' approach proves true for NASDAQ:CDXS I
Show less
Read more
Impact Snapshot
Event Time:
CDXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDXS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDXS alerts
High impacting Codexis, Inc. news events
Weekly update
A roundup of the hottest topics
CDXS
News
- Codexis to Report First Quarter 2024 Financial Results on May 2GlobeNewswire
- Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board [Yahoo! Finance]Yahoo! Finance
- Codexis Appoints Carole Cobb, MBA, to Strategic Advisory BoardGlobeNewswire
- Favourable Signals For Codexis: Numerous Insiders Acquired Stock [Yahoo! Finance]Yahoo! Finance
- Scientific Industries Announces Industry Veteran, John Nicols, as New Board Member and Chairman of Scientific Bioprocessing Inc. [Yahoo! Finance]Yahoo! Finance
CDXS
Earnings
- 2/28/24 - Beat
CDXS
Sec Filings
- 3/6/24 - Form 8-K
- 2/28/24 - Form 10-K
- 2/28/24 - Form 8-K
- CDXS's page on the SEC website